SequelSEC

HEALTHEQUITY, INC. HQY

Services-Business Services, NEC · CIK 0001428336 · Fiscal year ends 0131

AnnualQuarterlyTTM
Revenue
$1.36B
Fiscal year ended 2026-07-31
Operating income
$351.41M
Fiscal year ended 2026-07-31
Free cash flow
$487.72M
Fiscal year ended 2026-07-31

HEALTHEQUITY, INC. (HQY) reported revenue of $1.36B and net income of $236.49M for the fiscal year ended 2026-07-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from HEALTHEQUITY, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Business Services, NEC.

Income

HEALTHEQUITY, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Revenue$1.36B
Cost of revenue$391.65M
Gross profit$970.48M
Operating income$351.41M
Net income$236.49M
Research & development$277.96M
Weighted-average diluted sharesUnavailable
Pretax income$308.71M
Income tax expense$72.22M
Diluted EPSUnavailable
Selling, general & administrative$229.79M
General & administrative$130.41M
Selling & marketing$99.38M

Balance

HEALTHEQUITY, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Cash & equivalents$256.00M
Total assets$3.27B
Current assets$460.20M
Total liabilities$1.28B
Current liabilities$153.78M
Total equity incl. NCI$1.99B
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$122.19M
Goodwill$1.65B
Long-term debt$931.06M
Accounts payable$8.59M

Cash flow

HEALTHEQUITY, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Operating cash flow$490.18M
Capital expenditures$2.45M
Investing cash flow-$59.64M
Financing cash flow-$479.00M
Net change in cash-$48.46M
Stock-based compensation$81.28M
Common dividends paidUnavailable
Common share repurchases$404.50M
Depreciation & amortization$157.63M

Derived

HEALTHEQUITY, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Free cash flow$487.72M
Gross margin71.2%
Operating margin25.8%
FCF margin35.8%
SBC / revenue6.0%
Current ratio2.99x
Revenue YoY growth7.3%
Net margin17.4%
R&D / revenue20.4%
CapEx / revenue0.2%
Long-term debt / equity0.47x
Effective tax rate23.4%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HQY in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-27View SEC filing
10-Q · Filed 2026-05-28View SEC filing
10-K · Filed 2026-03-17View SEC filing
10-Q · Filed 2025-12-03View SEC filing
10-Q · Filed 2025-09-02View SEC filing
10-Q · Filed 2025-06-03View SEC filing

Companies in the same industry

ACN ACVA ADV AKAM ALIT AMTM AMWL ANDG ASFH BAER BCRD BR

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.